Robert Avery, MD
Show Description +
Robert Avery, MD, discusses 2-year results from the subretinal RGX-314 study, as well as the latest on the AAVIATE and ALTITUDE suprachoidal trials for wet AMD.
Posted: 11/01/2021
Robert Avery, MD
Robert Avery, MD, discusses 2-year results from the subretinal RGX-314 study, as well as the latest on the AAVIATE and ALTITUDE suprachoidal trials for wet AMD.
Posted: 11/01/2021
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of AAO: 2021.
Please log in to leave a comment.